Sinduya Krishnarajah

Ms. Sinduya Krishnarajah

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
AAAna Amorim
Ana Amorim
DFDonatella De Feo
Donatella De Feo
EFEkaterina Friebel
Ekaterina Friebel
FIFlorian Ingelfinger
Florian Ingelfinger
CACyrill Dimitri Anderfuhren
Cyrill Dimitri Anderfuhren
BBBurkhard Becher
Burkhard Becher

14 February 2024 in Nature Immunology
Verified
Journal Article
Open access
PDF file
TWTobias Wertheimer
Tobias Wertheimer
PZPascale Zwicky
Pascale Zwicky
LRLukas Rindlisbacher
Lukas Rindlisbacher
CSColin Sparano
Colin Sparano
MVMarijne Vermeer
Marijne Vermeer
BBBurkhard Becher
Burkhard Becher
Interleukin-23 (IL-23) is a proinflammatory cytokine mainly produced by myeloid cells that promotes tumor growth in various preclinical cancer models and correlates with adverse outcomes. However, as to how IL-23 fuels tumor growth is unclear. Here, we found tumor-associated macrophages to be the main source of IL-23 in mouse and human tumor microenvironments. Among IL-23-sensing cells, we identified a subset of tumor-infiltrating regulatory T (Treg) cells that display a highly suppressive phenotype across mouse and human tumors. The use of three preclinical models of solid cancer in combination with genetic ablation of Il23r in Treg cells revealed that they are responsible for the tumor-promoting effect of IL-23. Mechanistically, we found that IL-23 sensing represents a crucial signal driving the maintenance and stabilization of effector Treg cells involving the transcription factor Foxp3. Our data support that targeting the IL-23/IL-23R axis in cancer may represent a means of eliciting antitumor immunity.

19 June 2023 in Nature Immunology
Verified
Journal Article
Open access
PDF file
DCDilay Cansever
Dilay Cansever
EPEkaterina Petrova
Ekaterina Petrova
SKSinduya Krishnarajah
Sinduya Krishnarajah
CMCaroline Mussak
Caroline Mussak
CWChristina A. Welsh
Christina A. Welsh
MGMelanie Greter
Melanie Greter
Macrophages are involved in immune defense, organogenesis and tissue homeostasis. Macrophages contribute to the different phases of mammary gland remodeling during development, pregnancy and involution postlactation. Less is known about the dynamics of mammary gland macrophages in the lactation stage. Here, we describe a macrophage population present during lactation in mice. By multiparameter flow cytometry and single-cell RNA sequencing, we identified a lactation-induced CD11c+CX3CR1+Dectin-1+ macrophage population (liMac) that was distinct from the two resident F4/80hi and F4/80lo macrophage subsets present pregestationally. LiMacs were predominantly monocyte-derived and expanded by proliferation in situ concomitant with nursing. LiMacs developed independently of IL-34, but required CSF-1 signaling and were partly microbiota-dependent. Locally, they resided adjacent to the basal cells of the alveoli and extravasated into the milk. We found several macrophage subsets in human milk that resembled liMacs. Collectively, these findings reveal the emergence of unique macrophages in the mammary gland and milk during lactation.

16 December 2021 in Nature Aging
Verified
Journal Article
Open access
PDF file
SKSinduya Krishnarajah
Sinduya Krishnarajah
FIFlorian Ingelfinger
Florian Ingelfinger
EFEkaterina Friebel
Ekaterina Friebel
DCDilay Cansever
Dilay Cansever
AAAna Amorim
Ana Amorim
BBBurkhard Becher
Burkhard Becher
Aging exerts profound and paradoxical effects on the immune system, at once impairing proliferation, cytotoxicity and phagocytosis, and inducing chronic inflammation. Previous studies have focused on individual tissues or cell types, while a comprehensive multisystem study of tissue-resident and circulating immune populations during aging is lacking. Here we reveal an atlas of age-related changes in the abundance and phenotype of immune cell populations across 12 mouse tissues. Using cytometry-based high parametric analysis of 37 mass-cytometry and 55 spectral flow-cytometry parameters, mapping samples from young and aged animals revealed conserved and tissue-type-specific patterns of both immune atrophy and expansion. We uncovered clear phenotypic changes in both lymphoid and myeloid lineages in aged mice, and in particular a contraction in natural killer cells and plasmacytoid dendritic cells. These changes correlated with a skewing towards myelopoiesis at the expense of early lymphocyte genesis in aged mice. Taken together, this atlas represents a comprehensive, systematic and thorough resource of the age-dependent alterations of the mammalian immune system in lymphoid, barrier and solid tissues.

7 March 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
SKSinduya Krishnarajah
Sinduya Krishnarajah
BBBurkhard Becher
Burkhard Becher
The invasion of immune cells into the central nervous system (CNS) is a hallmark of the process we call neuroinflammation. Diseases such as encephalitides or multiple sclerosis (MS) are characterised by the dramatic influx of T lymphocytes and monocytes. The communication between inflammatory infiltrates and CNS resident cells is primarily mediated through cytokines. Over the years, numerous cytokine networks have been assessed to better understand the development of immunopathology in neuroinflammation. In MS for instance, many studies have shown that CD4+T cells infiltrate the CNS and subsequently lead to immunopathology. Inflammatory CD4+T cells, such as TH1, TH17, GM-CSF-producing helper T cells are big players in chronic neuroinflammation. Conversely, encephalitogenic or meningeal regulatory T cells (TREGs) and TH2 cells have been shown to drive a decrease in inflammatory functions in microglial cells and thus promote a neuroprotective microenvironment. Recent studies report overlapping as well as differential roles of these cells in tissue inflammation. Taken together, this suggests a more complex relationship between effector T cell subsets in neuroinflammation than has hitherto been established. In this overview, we review the interplay between helper T cell subsets infiltrating the CNS and how they actively contribute to neuroinflammation and degeneration. Importantly, in this context, we will especially focus on the current knowledge regarding the contribution of various helper cell subsets to neuroinflammation by referring to their helper T cell profile in the context of their target cell.

24 April 2023 in Nature Immunology
Verified
Journal Article
Open access
PDF file
NNNicolás Gonzalo Nuñez
Nicolás Gonzalo Nuñez
JSJonas Schmid
Jonas Schmid
LPLaura Power
Laura Power
CAChiara Alberti
Chiara Alberti
SKSinduya Krishnarajah
Sinduya Krishnarajah
BBBurkhard Becher
Burkhard Becher
The range of vaccines developed against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) provides a unique opportunity to study immunization across different platforms. In a single-center cohort, we analyzed the humoral and cellular immune compartments following five coronavirus disease 2019 (COVID-19) vaccines spanning three technologies (adenoviral, mRNA and inactivated virus) administered in 16 combinations. For adenoviral and inactivated-virus vaccines, heterologous combinations were generally more immunogenic compared to homologous regimens. The mRNA vaccine as the second dose resulted in the strongest antibody response and induced the highest frequency of spike-binding memory B cells irrespective of the priming vaccine. Priming with the inactivated-virus vaccine increased the SARS-CoV-2-specific T cell response, whereas boosting did not. Distinct immune signatures were elicited by the different vaccine combinations, demonstrating that the immune response is shaped by the type of vaccines applied and the order in which they are delivered. These data provide a framework for improving future vaccine strategies against pathogens and cancer.